Rankings
Fortune 500 India
Most Powerful Women
The Next 500
Forty Under Forty
Best B-Schools
MNC 500

Profiles
Companies
People

Markets
Cryptocurrency
IPO
Stock Market

Personal Finance
Tax
Mutual Funds
Banking

Magazine Annual Subscription

Archives
Enterprise
Investing
Macro
Infographics

Home
- News
- Media
- Magazine
- Rankings
- Profiles
  - Companies
  - People

NDCT rules

(1 search result)

India now prime destination for big pharma's global clinical trials

India now prime destination for big pharma's global clinical trials

Feb 15, 2022 7:49pm IST

HomeTopicNDCT rules

Follow us

Published by the RP-Sanjiv Goenka Group, Fortune India - the Indian edition of Fortune magazine - sets the benchmark for editorial excellence and thought leadership in Indian business journalism.

Fortune 500 India
Most Powerful Women
The Next 500
Forty Under Forty
Best B-Schools
MNC 500

Profiles

Companies
People

Most Read Sections

Business
Markets
Economy
Personal Finance
Opinion

Media

Videos
Short Videos
Visual Stories

June 2025
May 2025
April 2025
March 2025
February 2025
January 2025

Privacy & Cookie Policy
Terms of Use
Vision & Core Values
Contact Us

© 2025 Fortune India. All Rights Reserved.